HomeQuestion

In which patients are referring for focal gland therapy for localized prostate cancer?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?

How can you manage a patient with bilateral PCNs who requires Pluvicto administration?

How do you interpret isolated PSMA-avid sites in a patient with prostate cancer with no pelvic or RP LN uptake?

In mCRPC patients who had an initial response to Pluvicto but progress within 12 months, where do you position PSMA radioligand retreatment relative to other next-line systemic options in your sequencing strategy?

Will you extrapolate EORTC 1333/PEACE-3 (enzalutamide + Rad223) to any other ARPIs for mCRPC?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.